Rock Springs Capital Management LP Kymera Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $1.67 Billion
- Q1 2025
A detailed history of Rock Springs Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 794,437 shares of KYMR stock, worth $35.9 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
794,437
Previous 1,034,137
23.18%
Holding current value
$35.9 Million
Previous $41.6 Million
47.74%
% of portfolio
1.3%
Previous 1.66%
Shares
18 transactions
Others Institutions Holding KYMR
# of Institutions
178Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$303 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$292 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$271 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$271 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$236 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.47B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...